Found: 14
Select item for more details and to access through your institution.
Pragmatic considerations for negative control outcome studies to guide non‐randomized comparative analyses: A narrative review.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 599, doi. 10.1002/pds.5623
- By:
- Publication type:
- Article
Validation to correct for outcome misclassification bias.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 700, doi. 10.1002/pds.5601
- By:
- Publication type:
- Article
Trends in dispensed prescriptions for opioids, sedatives, benzodiazepines, gabapentin, and stimulants to children by general dentists, 2012–2019.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 625, doi. 10.1002/pds.5589
- By:
- Publication type:
- Article
Cases of acquired hemophilia A following COVID‐19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 694, doi. 10.1002/pds.5615
- By:
- Publication type:
- Article
Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta‐analysis of randomized controlled trials (CDM‐J).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 671, doi. 10.1002/pds.5594
- By:
- Publication type:
- Article
mRNA COVID‐19 vaccination early in pregnancy and the risk of spontaneous abortion in an international pregnancy registry.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 685, doi. 10.1002/pds.5600
- By:
- Publication type:
- Article
Tying research question and analytical strategy when variables are affected by medication use.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 661, doi. 10.1002/pds.5599
- By:
- Publication type:
- Article
Women on diuretics have a higher risk of hospital admission because of hyponatremia than men.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 635, doi. 10.1002/pds.5592
- By:
- Publication type:
- Article
"Take up to eight tablets per day": Incorporating free‐text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 651, doi. 10.1002/pds.5595
- By:
- Publication type:
- Article
Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community‐dwelling older patients acutely admitted to hospital? A Norwegian registry‐based study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 607, doi. 10.1002/pds.5590
- By:
- Publication type:
- Article
Outpatient fluoroquinolone use in relation to European Medicines Agency's recommendation: An Estonian nationwide drug utilization study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 643, doi. 10.1002/pds.5593
- By:
- Publication type:
- Article
Methods to refine and extend a Pregnancy Register in the UK Clinical Practice Research Datalink primary care databases.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 617, doi. 10.1002/pds.5584
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 704, doi. 10.1002/pds.5464
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 6, p. 1, doi. 10.1002/pds.5463
- Publication type:
- Article